Bacterial modulation of noncanonical inflammasome

非典型炎症小体的细菌调节

基本信息

项目摘要

Project Summary/Abstract The innate immune system employs germline-encoded pattern recognition receptors to survey the extra- and intra-cellular milieu for the presence of invading microbial or danger signals and mount appropriate defense responses. Inflammasomes, the multiprotein complexes assembled in the cytosol in response to microbial and endogenous danger signals, have emerged as a central component of the innate immune surveillance system. Once assembled inflammasomes proteolytically activate caspase-1, which in turn induces cell death and production of IL-1β and IL-18. Most recently a noncanonical NLRP3 inflammasome pathway was identified that is activated by LPS that enters the cytosol via outer membrane vesicles during infection with Gram-negative bacteria such as Enterohemorrhagic E. coli (EHEC). Cytosolic LPS binds and activates an inflammatory caspase, caspae-11, which then mediates cell death, caspase-1 activation and downstream IL-1 cytokine production. Inflammasomes, including the caspase-11-mediated noncanonical inflammasome, play a crucial role in the clearance of infectious agents via pyroptotic and IL-1 responses. A strong selection pressure from the host such as this drives pathogens to develop strategies to actively antagonize or evade innate immune responses. However, little is known about regulation of caspase-11- mediated noncanonical inflammasome by bacterial pathogens. This project will address this knowledge gap and will focus on examining the modulation of noncanonical inflammasome by bacteria utilizing EHEC as a model organism. The studies proposed in the three specific aims of this project will systematically characterize how two bacterial virulence factors inhibit the noncanonical inflammasome and determine the underlying mechanisms. Identifying the mechanisms by which pathogenic bacteria silence noncanonical inflammasome is crucial as it may aid in designing novel therapeutic approaches against Gram-negative infections.
项目总结/摘要 先天免疫系统利用种系编码的模式识别受体, 调查细胞内外环境是否存在入侵微生物或危险 发出信号,并采取适当的防御措施。炎性小体,多蛋白复合物 响应微生物和内源性危险信号在胞质溶胶中组装, 成为先天免疫监视系统的核心组成部分。一旦组装 炎性小体蛋白水解激活半胱天冬酶-1,半胱天冬酶-1又诱导细胞死亡, 产生IL-1β和IL-18。最近,非经典NLRP 3炎性体通路 被LPS激活,LPS通过外膜囊泡进入胞质溶胶 在感染革兰氏阴性菌如肠出血性大肠杆菌期间,大肠杆菌(EHEC)。 胞质LPS结合并激活炎性半胱天冬酶,casino-11,然后介导 细胞死亡、半胱天冬酶-1活化和下游IL-1细胞因子产生。炎性小体, 包括半胱天冬酶-11介导的非典型炎性小体,在 通过热原和IL-1应答清除感染因子。强大的选择压力 这种来自宿主的感染促使病原体发展出主动对抗或 逃避先天免疫反应然而,对caspase-11的调控知之甚少, 细菌病原体介导的非典型炎性小体。该项目将解决 这方面的知识差距,并将集中在检查非典型炎性小体的调制 利用肠出血性大肠杆菌作为模式生物。在三个具体的研究中, 该项目的目的将系统地描述两种细菌毒力因子如何抑制 非典型炎性小体,并确定潜在的机制。识别 致病菌沉默非典型炎性小体的机制是至关重要的, 可能有助于设计针对革兰氏阴性菌感染的新治疗方法。

项目成果

期刊论文数量(6)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Inflammasome activation and evasion by bacterial pathogens.
  • DOI:
    10.1016/j.coi.2020.11.006
  • 发表时间:
    2021-03
  • 期刊:
  • 影响因子:
    7
  • 作者:
    Ta A;Vanaja SK
  • 通讯作者:
    Vanaja SK
Shiga toxin suppresses noncanonical inflammasome responses to cytosolic LPS.
  • DOI:
    10.1126/sciimmunol.abc0217
  • 发表时间:
    2020-11-27
  • 期刊:
  • 影响因子:
    24.8
  • 作者:
    Havira MS;Ta A;Kumari P;Wang C;Russo AJ;Ruan J;Rathinam VA;Vanaja SK
  • 通讯作者:
    Vanaja SK
A bacterial autotransporter impairs innate immune responses by targeting the transcription factor TFE3.
  • DOI:
    10.1038/s41467-023-37812-2
  • 发表时间:
    2023-04-11
  • 期刊:
  • 影响因子:
    16.6
  • 作者:
    Ta, Atri;Ricci-Azevedo, Rafael;Vasudevan, Swathy O.;Wright, Skylar S.;Kumari, Puja;Havira, Morena S.;Surendran Nair, Meera;Rathinam, Vijay A.;Vanaja, Sivapriya Kailasan
  • 通讯作者:
    Vanaja, Sivapriya Kailasan
A TLR4-independent critical role for CD14 in intracellular LPS sensing.
CD14在细胞内LPS传感中无关TLR4的关键作用。
  • DOI:
    10.1016/j.celrep.2022.110755
  • 发表时间:
    2022-05-03
  • 期刊:
  • 影响因子:
    8.8
  • 作者:
    Vasudevan, Swathy O.;Russo, Ashley J.;Kumari, Puja;Vanaja, Sivapriya Kailasan;Rathinam, Vijay A.
  • 通讯作者:
    Rathinam, Vijay A.
Shigella "Osp"pression of innate immunity.
先天免疫的志贺氏菌“Osp”抑制。
  • DOI:
    10.1016/j.cell.2022.05.027
  • 发表时间:
    2022
  • 期刊:
  • 影响因子:
    64.5
  • 作者:
    Wright,SkylarS;Vanaja,SivapriyaKailasan
  • 通讯作者:
    Vanaja,SivapriyaKailasan
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Sivapriya Kailasan Vanaja其他文献

Sivapriya Kailasan Vanaja的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Sivapriya Kailasan Vanaja', 18)}}的其他基金

Outer Membrane Vesicles in Shiga Toxin-Mediated Inflammatory and Thrombotic Responses Leading to Systemic Disease
志贺毒素介导的导致全身性疾病的炎症和血栓反应中的外膜囊泡
  • 批准号:
    10668016
  • 财政年份:
    2023
  • 资助金额:
    $ 39.88万
  • 项目类别:
Bacterial modulation of noncanonical inflammasome
非典型炎症小体的细菌调节
  • 批准号:
    9520701
  • 财政年份:
    2018
  • 资助金额:
    $ 39.88万
  • 项目类别:
Bacterial modulation of noncanonical inflammasome
非典型炎症小体的细菌调节
  • 批准号:
    10893667
  • 财政年份:
    2018
  • 资助金额:
    $ 39.88万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 39.88万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 39.88万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 39.88万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 39.88万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 39.88万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 39.88万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 39.88万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 39.88万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 39.88万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 39.88万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了